Some of the most common tumor types that utilize the G-CSF particularly as primary prophylaxis are breast cancer, lung cancer, non-Hodgkin lymphoma, and prostate cancer [6–9] with an average of about 20% across various metastatic cancers in the US [10]. This evidence concerns the gene CSF3 and lung cancer.